title: [Susceptibility to varicella among health care workers. Acceptability and response to vaccination].
abstract: OBJECTIVE
  To determine the prevalence of health care workers (HCW) susceptibility to varicella zoster virus (VZV). As a secondary objective, we describe the immunogenicity and reactogenicity of the vaccine.
  
  
  METHODS
  A multicenter analytic cross-sectional study was conducted in 5 hospitals in Catalonia, Spain, in a total of 1,111 HCW, aged between 18-60 years. We studied the prevalence of anti-VZV antibodies (IgG) and obtained demographic, occupational and health related variables that were expected to be associated with immunogenicity, as well as past history of varicella. All susceptible HCW were vaccinated and we studied the immunogenicity (antibody detection) and reactogenicity of the 1st and 2nd doses of the vaccine. Detection of antibodies against VZV was obtained by ELISA. All negative results were confirmed with FAMA.
  
  
  RESULTS
  Forty two subjects (3.8%) were negative. Susceptibility to VZV was associated (p<0.05) with decreased age (29.6 years ± 8.5 vs. 32,5 ± 9,3 in non-susceptible individuals), having fewer siblings and having no previous clinical history of varicella. Postvaccination detection tests with ELISA showed a seroconversion rate of 52 and 86% after the 1st and 2nd doses of the vaccine respectively, and 100% when using FAMA. There were no significant adverse events.
  
  
  CONCLUSIONS
  Susceptibility to varicella among HCW is low. Positive past history of varicella is a good predictor of previous exposure to VZV, since 99% (687/696) of the individuals that declared having experienced the disease were immune. This would avoid prevaccination screening in nearly two thirds of HCW.
authors.affiliation: Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic, Universitat de Barcelona, Barcelona, España. basteiro@clinic.ub.es
authors.forename: Alberto L
authors.initials: AL
authors.lastname: García-Basteiro
authors.forename: José-María
authors.initials: JM
authors.lastname: Bayas
authors.forename: Magda
authors.initials: M
authors.lastname: Campins
authors.forename: Miquel
authors.initials: M
authors.lastname: Torres
authors.forename: Consol
authors.initials: C
authors.lastname: Serra
authors.forename: Pilar
authors.initials: P
authors.lastname: Varela
authors.forename: Esther
authors.initials: E
authors.lastname: Barbé
authors.forename: Josep
authors.initials: J
authors.lastname: Vidal
mesh_terms: D000293:Adolescent; D000328:Adult; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D002644:Chickenpox / Q000453:epidemiology / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000276:immunology; D003430:Cross-Sectional Studies; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000453:epidemiology / Q000517:prevention & control*; D015995:Prevalence; D055815:Young Adult
chemical_list: D019433:Chickenpox Vaccine